Subtype
Diffuse Midline Glioma
CI-CAN-00005114Explore in graph →
61 active trials1 approved drugs15 evidence items
- NCIt
- C182151
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005114Explore in graph →
Provenance
Every source that supplied a code, alias, edge, observation or derived value, with the ingest runs involved.
| Source | License | Contributions | Ingest runs | Last retrieved |
|---|---|---|---|---|
| CIViC — Clinical Interpretation of Variants in Cancer civic | approved | Evidence | ING-CIVIC-20260929-000001 | Sep 29, 2026, 02:13 AM UTC |
| NCI Thesaurus (NCIt) ncit-evs | approved | Aliases, Codes, Description, Hierarchy, Source Records | ING-NCITEVS-20260908-000001 | Sep 8, 2026, 09:44 AM UTC |
| openFDA — Drugs@FDA applications and drug labels (SPL) openfda | approved | Approvals | — | Sep 28, 2026, 04:02 AM UTC |
| PubMed (NCBI E-utilities) pubmed | approved | Literature Counts | ING-PUBMED-20260912-000001 | Sep 12, 2026, 03:00 AM UTC |
Identifiers
Every upstream identifier is kept with its match type; nothing is buried in JSON.
Names
| Alias | Type | Terminology | Language |
|---|---|---|---|
| Diffuse Midline Glioma | preferred | NCIt | en |
Change history
Creation, updates, merges and ranking changes recorded for this entity.